Haemophilia A and B and von Willebrand patients

In the last 3 months (July, August, September 2025), how many haemophilia A and B and von Willebrand patients were treated with the following coagulation factors in your trust and how much volume (IUs or mg) was used?

Medway NHS Foundation Trust is not a registered Haemophilia Centre. All local patients are registered with the Regional Haemophilia Centre at Kent and Canterbury Hospital, East Kent Hospitals University NHS Foundation Trust, who are contactable via their website

Shared care is provided and a joint clinic is held at Medway every 3 months in which well/asymptomatic patients with ‘mild’ bleeding disorders are reviewed by the Haemophilia Consultant.

All patients with moderate or severe bleeding disorders are seen only at Canterbury.

Occasionally, a Haemophilia patient may present to the Emergency Department with bleeding, or require treatment prior to elective surgery which is being performed at Medway.

Patients are treated with Factor VIII or IX concentrate as advised by the Haemophilia Centre team, and the Factor Concentrate Product is transferred from Canterbury.

In our Medway Transfusion Laboratory we keep a very limited supply of Advate, BeneFIX and Voncento for emergency use only.

The Trust can confirm that none of the products listed below have been issued within the requested timeframe.

• Hemlibra (non-inhibitor patients)
• Hemgenix
• Altuvoct
• Advate
• Adynovi
• Elocta
• Esperoct
• NovoEight
• ReFacto AF
• Nuwiq
• Hympavzi
• Idelvion
• Refixia
• Alprolix
• BeneFIX
• Replenine
• Rixubis
• Veyvondi
• Voncento
• Wilate
• Willfact